Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2467${count})

  • Community Fast Track, 2005
    K-ATP Channels and Their Role in the Survival of Nigral Dopaminergic Neurons

    ATP-sensitive potassium (K-ATP) channels are present is numerous tissues including the brain. Their function has been best studied in the pancreatic B-islet cells that participate in the regulation of...

  • Community Fast Track, 2005
    Use of NR2D-selective NMDA Receptor Modulators in the Treatment of PD

    The frontline pharmacological treatment for Parkinson's disease is associated with serious side effects, creating a need for new therapeutic strategies. Recent evidence suggests that selective...

  • Community Fast Track, 2005
    The role of serotonin neurons in the induction and maintenance of dyskinesias in grafted and L-DOPA-primed animals

    Background: Levodopa, the most commonly used medication for patients with Parkinson's disease, is a beneficial therapy, but as the disease progresses it can be the cause of debilitating involuntary...

  • LEAPS, 2005
    New Small Molecule Inhibiting Agents of Alpha-Synuclein & Lewy Body Formation as Disease-Modifying Treatments for Parkinson's Disease

    Parkinson's Disease is pathologically characterized by the presence and accumulation of a protein known as alpha-synuclein. Mutations in alpha-synuclein have been directly linked to PD, and alpha...

  • LEAPS, 2005
    Development and Optimization of a Regulatable Gene Switch for Gene Therapies of Parkinson’s Disease

    Gene therapy holds tremendous potential for the treatment of Parkinson's disease. By using a virus or other DNA delivery system to permanently insert a new gene into critical regions of a Parkinson...

  • Target Validation, 2005
    Testing of small molecules in an alpha-synuclein pre-clinical model of Parkinson’s disease

    Although Parkinson’s disease is mainly sporadic, at least six genes have been recently linked to familial PD. It is believed that a molecular understanding of the consequences of these gene mutations...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.